ArrowMark Colorado Holdings’s Sana Biotechnology SANA Stock Holding History

ArrowMark Colorado Holdings’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Hold	685,125	–	–	0.1%	219
2026 Q1	$1.97M	Hold	685,125	–	–	0.05%	219
2025 Q4	$2.79M	Hold	685,125	–	–	0.06%	222
2025 Q3	$2.43M	Hold	685,125	–	–	0.05%	227
2025 Q2	$1.87M	Hold	685,125	–	–	0.03%	233
2025 Q1	$1.15M	Hold	685,125	–	–	0.02%	245
2024 Q4	$1.12M	Hold	685,125	–	–	0.02%	256
2024 Q3	$2.85M	Hold	685,125	–	–	0.04%	216
2024 Q2	$3.74M	Hold	685,125	–	–	0.04%	221
2024 Q1	$6.85M	Hold	685,125	–	–	0.08%	185
2023 Q4	$2.8M	Buy	685,125 +216,376	+46%	+$797K	0.03%	227
2023 Q3	$1.81M	Buy	+468,749	New	+$2.52M	0.02%	239

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

ArrowMark Colorado Holdings's SANA Position: Q2 2026 in Review

ArrowMark Colorado Holdings held its Sana Biotechnology (SANA) position steady in Q2 2026 at 685,125 shares worth $2.39M. The position accounts for 0.1% of the portfolio, ranked #219.

ArrowMark Colorado Holdings first reported a position in SANA in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.85M in Q1 2024. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

ArrowMark Colorado Holdings held 685,125 shares of Sana Biotechnology worth $2.39M as of Q2 2026.
ArrowMark Colorado Holdings left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up 0.1% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #219 holding.
ArrowMark Colorado Holdings first reported a position in Sana Biotechnology in Q3 2023 and has held it in 12 quarters since.
ArrowMark Colorado Holdings's Sana Biotechnology position peaked at $6.85M in Q1 2024.
212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.